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Abstract 
Salmonella enterica is a Gram-negative bacterium that causes gastroenteritis, bacteremia and 
typhoid fever in several animal species including humans. Its virulence is greatly dependent 
on two type III secretion systems, encoded in pathogenicity islands 1 and 2. These systems 
translocate proteins called effectors into eukaryotic host cell. Effectors interfere with host 
signal transduction pathways to allow the internalization of pathogens and their survival and 
proliferation inside vacuoles. SteA is one of the few Salmonella effectors that are substrates 
of both type III secretion systems. Here, we used gene arrays and bioinformatics analysis to 
study the genetic response of human epithelial cells to SteA. We found that constitutive 
synthesis of SteA in HeLa cells leads to induction of genes related to extracellular matrix 
organization and regulation of cell proliferation and serine/threonine kinase signaling 
pathways. SteA also causes repression of genes related to immune processes and regulation 
of purine nucleotide synthesis and pathway-restricted SMAD protein phosphorylation. In 
addition, a cell biology approach revealed that epithelial cells expressing steA show altered 
cell morphology, and decreased cytotoxicity, cell-cell adhesion and migration. 
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1. Introduction 
Many pathogenic Gram-negative bacteria possess type III secretion systems (T3SSs) for their 
interaction with the host. These systems allow delivery into eukaryotic host cells of effector 
proteins that direct the different stages of the infection at the cellular level [1]. Salmonella 
enterica possesses two distinct virulence-related T3SSs, T3SS1 and T3SS2, that are encoded 
by genes located in Salmonella pathogenicity islands 1 and 2 (SPI1 and SPI2), respectively 
[2]. T3SS1 is necessary for the invasion of non-phagocytic cells [3], whereas T3SS2 is 
induced after invasion and is essential for survival and replication within macrophages [4,5]. 
S. enterica injects more than thirty T3SS effectors to their host cells and some of them have 
been shown to manipulate cellular processes such as actin cytoskeleton organization, tight 
junction alterations, biogenesis of the Salmonella-containing vacuole and cell death [6]. 
However, the functions for many effectors are still unknown.  
SteA was identified as a S. enterica serovar Typhimurium T3SS effector [7] that can be 
secreted to culture media and translocated into epithelial cells and macrophages through 
T3SS1 and T3SS2, depending on culture conditions, infected cell types and infection times. 
The first 10 amino acids of SteA act as a signal sequence for its translocation into the 
eukaryotic cell [8]. The gene steA is located outside SPI1 and SPI2, and its low GC content 
(43%) suggests horizontal acquisition, common in virulence-associated genes. We have 
previously shown that its expression is transcriptionally controlled by the bacterial redox 
status in a PhoQ/PhoP-dependent manner [9]. A steA null mutant is three-fold attenuated for 
BALB/c mice virulence after intraperitoneal infection [7] and SteA seems to be involved in 
the bacterial persistence during long time infection in 129X1/SvJ mice [10]. In the host cell, 
SteA localizes to the trans-Golgi network (TGN) and to Salmonella-induced membrane 
tubules containing the trans-Golgi marker GalT-mCherry [7,11]. A very recent report has 
shown that SteA participates in the control of Salmonella-containing vacuole membrane 
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dynamics	  [12]. This study also suggests that SteA should have additional roles, which remain 
to be elucidated, at earlier times of host cell infection. 
Similarity to proteins with known activities has been useful in some cases to determine the 
function of a specific effector [13], but in the case of SteA no sequence similarities have been 
detected. Expression of individual effectors, like AvrA or SopB, in the budding yeast 
Saccharomyces cerevisiae, that serves as a simplified heterologous model [14], has been a 
productive approach to study the effects of these proteins on host cells [15,16,17], thereby 
helping in the discovery of their activities. Here, we use mammalian cells as a relevant model 
to specifically analyze the effect on the host transcriptome of the effector SteA. We show that 
in epithelial HeLa cells SteA leads to changes in the expression of genes related to 
extracellular matrix organization, cell proliferation, serine/threonine kinase signaling 
pathways, immune processes, regulation of purine nucleotide synthesis and pathway-
restricted SMAD protein phosphorylation, and produces significant changes in cell death, 
adhesion, and migration. 
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2. Materials and methods 
2.1. Bacterial strains and bacterial culture 
Bacterial strains used were Escherichia coli DH5α [18] and S. enterica serovar Typhimurium 
SV5846	  [8], a derivative of strain 14028 carrying a steA::3xFLAG chromosomal fusion. The 
standard bacterial culture medium was Luria-Bertani (LB) broth. Solid LB contained agar 
1.5% final concentration. Antibiotics were used at the following concentrations: kanamycin, 
50 µg/ml; ampicillin, 100 µg/ml. 
2.2 Plasmid construction, DNA amplification, and sequencing 
Plasmid pIZ1963 is a derivative of pBABEpuro [19] coding for SteA with a C-terminal 
3xFLAG tag. To construct this plasmid, steA::3xFLAG was amplified from strain SV5846 
using primers steApcdnadir and steAflagxho3, digested with BamHI and XhoI and ligated 
together with vector pBABEpuro previously digested with BamHI and SalI. Amplification 
reactions and confirmation by sequencing were carried out as previously described [8]. 
Primers are listed in Table S1. 
2.3 Mammalian cell culture, transfection and lysis 
HeLa cells (ECAC no. 93021013) were cultured, transfected, and lysed as previously 
described [20]. For stable transfection, HeLa cells were electroporated with pBABEpuro or 
its derivative and selection was started 24 h after electroporation in medium containing 1 
µg/ml puromycin (InvivoGen). 
2.4 Bacterial infection of cultured cells and analysis of SteA translocation 
HeLa cells were plated in 6-well plates at 6x105 cells per well and incubated for 24 h. 
Salmonella infections were carried out as previously described	  [8]. The cell culture was 
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washed twice with PBS 1 h post-infection and overlaid with DMEM containing 100 µg/ml 
gentamicin. One hour later the concentration of gentamicin was lowered to 16 µg/ml after an 
additional wash with PBS. Infected mammalian cells were lysed 6 h post-infection with 
Nonidet P-40 buffer as described	  [8]. The extract was centrifuged at 13000 rpm for 20 min 
and the supernatant was filtered and analyzed by immunoblot. 
2.5 Electrophoresis, immunoblot, and antibodies 
Proteins in cell extracts were resolved by SDS-PAGE. The gel was blotted onto a 
nitrocellulose membrane (Amersham) and probed with mouse monoclonal anti-FLAG M2 
primary antibodies (1:5000; Sigma) and mouse monoclonal anti-β-actin C4 (1:5000; Santa 
Cruz Biotech) as loading control. Goat anti-mouse horseradish peroxidase-conjugated 
antibodies (1:5000; BioRad) were used as secondary antibodies. Detection was via 
chemiluminescence procedures (Pierce). 
2.6 RNA preparation, gene array processing, and statistical analysis 
Total RNA from HeLa cells stably transfected with pBABEpuro or its derivative encoding 
the SteA-3xFLAG fusion was isolated in triplicate using 1 ml of TRIzol reagent (Invitrogen) 
according to the protocol supplied by the manufacturer. An additional purification step was 
carried out by using the RNeasy Min Elute Cleanup Kit (Qiagen). Biotinylated single-
stranded cDNA was prepared from 100 ng per sample of total intact RNA extracted from 9 
independent samples (3 from HeLa pBABEpuro, 3 from HeLa pBABEpuro-SteA-3xFLAG 
L2, and 3 from HeLa pBABEpuro-SteA-3xFLAG L4). Labelled cDNA was hybridized to 
GeneChip Human Gene 1.0 ST Arrays (Affymetrix) following the manufacturer’s 
instructions. The arrays were scanned in a 3000 7G Scanner from Affymetrix. Image analysis, 
fluorescent data quantification and quality control was carried out with Affymetrix software. 
All procedures and preliminary data analysis, including fluorescent data processing, 
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normalization using Robust Multi-array Average (RMA) algorithms, and annotations, were 
performed at the Genomics Unit of the Andalusian Center for Molecular Biology and 
Regenerative Medicine (CABIMER, Seville, Spain). Fold change was calculated for each cell 
line relative to the control line transfected with pBABEpuro. Statistical significance (p value) 
was calculated by empirical Bayes moderated t-test based on the results of three arrays per 
condition. The false discovery rate (FDR) for each p value was also calculated. Genes that 
changed with an FDR-adjusted p value higher than 0.05 were removed from subsequent 
analysis. The microarray data used in this analysis is available from NCBI’s Gene Expression 
Omnibus at http://www.ncbi.nlm.nih.gov/geo/ under accession number GSE51043. 
2.7 Function prediction of gene sets 
To predict the functional association networks of the activated and repressed genes from the 
microarray, we used the web-based software application tool GeneMANIA [21]. GO terms 
associated to genes in Table 1 were searched using AmiGO version 1.8 [22]. 
2.8 Quantitative real-time PCR (qPCR) 
The protocol for qPCR was previously described [9]. DNA primers are indicated in Table S1. 
Gene expression levels were normalized to transcripts of BCAT1, gene that appeared not 
affected by the presence of SteA in the microarray. 
2.9 Proliferation assays 
HeLa cells were seeded in 6-well plates at a density of 6x104 cells per well and grown at 
37ºC, 5% CO2 in DMEM. At 24 h intervals, the cells from a well per cell line were 
trypsinized and counted on a haemocytometer 
2.10 Cell death, cell adhesion, and cell migration assays 
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Cell death was measured using a previously described protocol based on lactate 
dehydrogenase (LDH) release in the cultures [20]. Cell adhesion was determined as 
previously described [23]. For cell-cell adhesion assays, 6x104 cells/ml were seeded onto 6-
well plates coated with poly-(2-hydroxyethyl methacrylate) (poly-HEMA) (Sigma) in order 
to prevent cell-matrix interactions. After 48 h of culture in suspension, cells were 
photographed on an inverted microscope. For the migration assay (wound closure assay), we 
followed the protocol previously described [24].  
2.11 Statistical analysis 
Student’s t test was used to analyze differences in growth, cytotoxicity percentage, and 
relative migration. p values of 0.05 or less were considered significant. 
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3. Results and Discussion 
3.1	  cDNA	  microarray	  analysis	  of	  gene	  expression	  in	  HeLa	  cells	  in	  response	  to	  SteA	  
To investigate the consequences of the presence of the Salmonella T3SS effector SteA in 
human epithelial cells, we generated three stably transfected HeLa cell lines, one with the 
empty vector pBABEpuro and two with a derivative of the same vector encoding a SteA-
3xFLAG fusion (lines SteA L2 and and SteA L4). The expression level of tagged SteA in 
these cell clones was determined by Western blot analysis and compared to the level of SteA 
translocated into HeLa cells during in vitro infections with S. enterica serovar Typhimurium 
strain SV5846. As seen in Figs. 1A and 1B, the level of SteA was higher in L4 than in L2. 
Importantly, in both cell lines the levels were lower than after translocation from Salmonella. 
This result suggests that the effects of SteA studied in this work are not due to a non-
physiological level of expression of the effector. Next, we performed microarray 
hybridization with RNA from stably transfected cells. Biotin-labelled cDNAs prepared from 
total RNA were hybridized to microarray chips containing 28,869 sequenced human genes. 
The number of genes that changed in response to SteA expression in a statistically significant 
manner (FDR-adjusted p value < 0.05) is represented in Fig. 1C (upregulated genes) and Fig. 
1D (downregulated genes) using Venn diagrams. As a result of this analysis we decided to 
focus on 58 genes (0.2 % of the whole human gene number analyzed) that showed 
differential expression in both of the cell lines expressing SteA (L2 and L4) when compared 
to the control cell line. Of these, 13 genes showed higher expression while 45 genes showed 
lower expression. These genes are listed in Table S2. A general conclusion that can be drawn 
from the microarray analysis is that the presence of SteA within HeLa cells causes more gene 
repression than activation. This is true for both stably transfected cell lines, L2 and L4. The 
	   10	  
fact that differential expression is more pronounced in L4, correlates with a higher level of 
SteA in this cell line. 
Figure 1 
3.2 Validation of microarray data 
To validate microarray results we selected 7 differentially expressed genes and performed 
qPCR assays. These experiments were carried out using new samples, independent from the 
ones used for the microarray. The gene expression changes measured by qPCR were in 
agreement with microarray data (Fig. 2).  
Figure 2 
3.3 Functions of the SteA-regulated genes 
To get insight into the cell functions affected by SteA, differentially expressed genes were 
used to search the GeneMANIA prediction server [21]. GeneMANIA uses a very large set of 
functional interaction data to find genes related to the list of query genes. Interaction data 
include co-expression, physical interactions, co-localization, shared protein domains, genetic 
interactions, and pathways. The resultant networks for the up- and downregulated genes are 
shown in Fig. S1. GeneMANIA also computes gene ontology (GO) enrichment on the 
resulting set of genes (query list plus related genes). The results of these analyses are shown 
in Table S3, for upregulated genes, and Table S4, for downregulated genes. From this study, 
we conclude that genes activated by SteA expression in HeLa epithelial cells are mainly 
related to extracellular matrix organization, cell proliferation and serine/threonine kinase 
signaling, whereas genes repressed by SteA are mainly involved in immune processes, 
regulation of purine nucleotide biosynthetic process and regulation of the pathway-restricted 
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SMAD protein phosphorylation. Additional functions affected by these genes that may be 
relevant in the context of Salmonella infections are shown in Table 1. 
3.4 SteA decreases epithelial cell death 
Since SteA has not been shown to have a nuclear localization, a direct function as a 
transcriptional regulator is unlikely. However, the observed alterations suggest that SteA 
significantly interferes with several host transduction pathways. Therefore, we decided to use 
data obtained in the transcriptomic analysis as a guide to study phenotypic alterations induced 
by SteA in HeLa cells. The functional analysis shown in the previous section revealed several 
genes whose expression could affect cell proliferation (Table 1). However, we were unable to 
detect differences in proliferation rates between HeLa pBABEpuro cells and HeLa 
pBABEpuro-SteA-3xFLAG cells under the experimental conditions used (Fig. 3A). 
Some of the genes upregulated (CTGF, C5AR1, MAP2K6) or downregulated (COL15A1, 
CYFIP2, IER3, NFE2L2, NOG, TGFB1, UNC13B) in the presence of SteA are involved in 
cell death. Thus, we decided to compare cell death in cultures of steA and vector-transfected 
cells. Fig. 3B shows a significant decrease in cytotoxicity in SteA expressing cells as 
determined by LDH release. This result suggests that SteA, together with other effectors like 
AvrA and SopB, whose antiapoptotic activities are already known	  [25,26], could contribute 
to the delay in cell death that is observed during infections of epithelial cells. This is probably 
beneficial for the pathogen because it allows the establishment of a stable intracellular niche 
and contributes to avoid adaptive immunity. 
Figure 3 
3.5 SteA induces changes in morphology, adhesion and migration of epithelial cells 
	   12	  
Strikingly, HeLa cells expressing SteA were more rounded and formed smaller colonies than 
control cells (Fig. 4A). We reasoned that these morphological alterations could be explained 
by the observed changes in the level of expression of genes related to cell adhesion 
(CNTNAP3, COL15A1, CTGF, CYFIP2, MPDZ, TGFB1), production or organization of the 
extracellular matrix (COL15A1, CTGF, EFEMP1, FURIN, LUM, SDC2, TGFB1), and cell 
migration (CAV1,CTGF, MYH10, SLC7A11, TGFB1, TNS1) (Table 1). To test these ideas we 
investigated adhesion and migration of steA-transfected cells. Interestingly, although 
adhesion to plastic substrate or extracellular matrix proteins (collagen I or vitronectin) was 
not altered in these cells (data not shown), cell-cell adhesion was clearly disrupted. To carry 
out the later experiments, cells were cultured in poly-HEMA treated plates. In this way, cells 
are not able to adhere to the plate and grow as a suspension but they can bind to other cells. 
Under these conditions, control cells formed dense aggregates whereas steA transfected cells 
were more loosely dispersed in the media, indicating a defect in intercellular binding (Fig. 
4B). In addition, cells constitutively producing the Salmonella effector SteA showed reduced 
migration ability in a wound closure assay (Figs. 4C and 4D). Taken together, these results 
suggest that the presence of SteA in epithelial host cells alters their morphology through a 
modification of their adhesion and migration properties. 
Figure 4 
The direct approach used here to investigate the impact of the Salmonella effector SteA on 
host cells has significant advantages. Since SteA is the only effector that is present in stably 
transfected HeLa cells all the effects observed should be ascribed to this effector. There are 
no interferences from other effectors. Actually, one of the hurdles in the study of the 
functions of T3SS effectors is the fact that sometimes they act redundantly or in opposite 
ways [27]. Functional redundancy or overlap can explain why mutants lacking only one 
effector are often as virulent as the wild type. Also, conditions for expression and 
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translocation of a particular effector are not always completely defined since they can depend 
on diverse factors including: Salmonella strain or serovar, culture conditions previous to 
infection, host cell type, and time post-infection. Our approach ensures constitutive 
expression throughout the experiments. Using this approach we have been successful in 
identifying changes in host cell gene expression and phenotypes triggered by SteA.  Overall, 
the results presented here suggest that the T3SS effector SteA can have a significant impact 
in the biology of Salmonella-infected host cells. Our results also open the possibility of 
studying in detail the role during infection of individual host genes whose expression is 
affected by SteA. 
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Figure legends 
Fig. 1. Expression of SteA-3xFLAG in stably transfected HeLa cells (A) HeLa cells were 
stably transfected with plasmids pBABEpuro (Vector) and pBABEpuro-SteA-3xFLAG (SteA 
L2 and SteA L4) or were infected with S. enterica serovar Typhimurium strain SV5846 
(Infected) and lysates were immunoblotted with monoclonal anti-FLAG antibodies and with 
antibodies against β-actin as a loading control. (B) Quantification of SteA-3xFLAG with 
respect to β-actin and normalization regarding the SteA L2 quantification. Means and 
standard deviations from two independent experiments are represented. (C and D) Venn 
diagrams of genes with differential expression between HeLa cells expressing SteA-3xFLAG 
and control HeLa cells. Number of significantly (FDR-adjusted p value < 0.05) upregulated 
(C) or downregulated (D) genes in clones expressing SteA-3xFLAG compared to the control 
(L2/Control and L4/Control) is shown. 
Fig. 2 Microarray and qPCR results for selected differentially expressed genes. (A) 
Microarray results of 7 differentially expressed genes in HeLa pBABEpuro-SteA-3xFLAG 
(SteA L2 and SteA L4) compared to HeLa pBABEpuro. (B) qPCR results showing mRNA 
relative amount of the same genes in the same strains. Means and standard deviations from 
three experiments performed in triplicate are represented. Gene names are indicated. M (log) 
is the log2 of the ratio L2/control or L4/control for each gene 
Fig. 3. Effect of SteA on cell death. (A) Proliferation of HeLa cells expressing SteA-
3xFLAG (SteA L4) compared to control cells (Vector) during a period of 5 days. (B) HeLa 
cells stably transfected with pBABEpuro (Vector) and pBABEpuro-SteA-3xFLAG (SteA L4) 
were cultured in serum-free medium for 24 h and cell death was determined by LDH release. 
Means from representative experiments carried out in triplicate are represented. Error bars 
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represent the standard deviations. The asterisk indicates a significant difference (p < 0.01) by 
the Student’s t test. 
Fig. 4. HeLa cells expressing SteA have a defect in cell-cell adhesion and cell migration. (A) 
HeLa cells stably transfected with pBABEpuro (Vector) and pBABEpuro-SteA-3xFLAG 
(SteA L4) were observed under an inverted microscope to detect differences in cellular shape 
(upper panels) and in cell colony shape (lower panels). (B) HeLa cells were transferred to 
poly-HEMA-coated plates. After 48 h of culture in suspension, cells were photographed 
under an inverted microscope. Depicted are control cells HeLa pBABEpuro (Vector), which 
form dense aggregates, and HeLa pBABEpuro-SteA-3xFLAG (SteA L4), which adhere to 
each other only very weakly. (C) Representative images of wound-healing assays showing 
that HeLa pBABEpuro (Vector) closed the wound 4 days after wounding, whereas HeLa 
pBABEpuro-SteA-3xFLAG (SteA L4) did not. Wounds are outlined. (D) Wound widths 
measured 48 h after wounding and normalized to the value obtained for HeLa pBABEpuro 
are graphed, showing means and standard deviations from six experiments. The asterisk 
indicates a significant difference (p < 0.01). Scale bars, 200 µm. 
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Table 1 
Selected biological functions associated to a subset of differentially expressed genes in steA-
transfected HeLa cells  
Upregulated 
genes 
Biological process or molecular function 
Proliferation Death/apoptosis ECMa Adhesion Migration Endocytosis 
CAV1 X    X X 
CCND1 X      
CTGF X X X X X  
C5AR1 X X     
C5orf23 (NPR3) X      
EFEMP1   X    
LUM   X    
MAP2K6  X     
SDC2   X    
Downregulated 
genes 
Biological process or molecular function 
Proliferation Death/apoptosis ECMa Adhesion Migration Endocytosis 
AKR1C2 X      
ALDH3A1 X      
CNTNAP3    X   
COL15A1  X X X   
CYFIP2  X  X   
FURIN X  X    
IER3  X     
MPDZ    X   
MYH10 X    X  
NFE2L2  X     
NOG X X     
RARRES1 X      
SLC7A11     X  
TGFB1 X X X X X  
TNS1     X  
UNC13B  X     
aECM: extracellular matrix regulation. X indicates that this GO term appears associated to this gene. 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure S1 
 
